Health
Turning CAR-T tech against solid tumors by targeting protein fragments in cancer cells – FierceBiotech
A University of Pennsylvania team has developed a new type of engineered immune cell called “peptide-centric” CAR-T that’s designed…
CAR-T therapies, which arm a patients own immune cells with cancer-fighting proteins, are currently used to treat some patients with blood cancers. But the technology has been hard to apply to other cancers, partly because of a lack of tumor-specific antigens…
Continue Reading
-
Noosa News17 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General15 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
General11 hours agoPerth man charged after investigation into organised crime and tobacco store attacks
-
Business18 hours agoSolid superannuation gains continue to roll in